UBS Group Boosts Cardinal Health (NYSE:CAH) Price Target to $160.00

Cardinal Health (NYSE:CAH – Get Free Report) had its price target increased by equities research analysts at UBS Group from $150.00 to $160.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price target would indicate a potential upside of 13.27% from the company’s current […]

Leave a Reply

Your email address will not be published.

Previous post QinetiQ Group (OTCMKTS:QNTQY) Upgraded at Royal Bank of Canada
Next post Lucas: We’ve had enough of judges letting criminals get away